Krystal Biotech has received FDA approval for the first-ever redosable gene therapy, VYJUVEK™. The treatment is a topical gel that is applied directly onto
DEBRA Svizzera
Bahnhofsstrasse 55
5001 Aarau
Tel.: 062 534 16 90
Per questioni amministrative:
sekretariat@schmetterlingskinder.ch
Per richieste dei media e donazioni:
debra@schmetterlingskinder.ch